United States · FDA National Drug Code directory
Lopinavir and Ritonavir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42385-933_3a3c4164-da47-427d-9f12-6d1f73b0729d
- Product NDC
- 42385-933
- Form
- TABLET, FILM COATED
- Composition / generic term
- Lopinavir and Ritonavir
- Labeler
- Laurus Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220322
- Source listing expiry
- 20261231
Source-listed ingredients
- LOPINAVIR — 100 mg/1
- RITONAVIR — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (42385-933-60) · 42385-933-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →